Nifty 50
- TCS₹2,34293.60 (4.16%)
- ICICI Bank₹1,422.80-20.20 (-1.40%)
- Tech Mahindra₹1,640.9055.90 (3.53%)
- Shriram Finance₹1,086.90-14.10 (-1.28%)
- Infosys₹1,14433.20 (2.99%)
- ITC₹266-3.00 (-1.12%)
- HCL Technologies₹1,316.1034.10 (2.66%)
- UltraTech Cement₹11,589-128.00 (-1.09%)
- Wipro₹180.954.55 (2.58%)
- Asian Paints₹2,608.70-22.30 (-0.85%)
- Bajaj Auto₹11,910190.00 (1.62%)
- SBI Life Insurance ₹1,761.10-12.10 (-0.68%)
- Hindalco Industries₹1,037.4013.40 (1.31%)
- Eicher Motors₹8,059-41.00 (-0.51%)
- HDFC Bank₹720.309.30 (1.31%)
- Maruti Suzuki₹13,376-64.00 (-0.48%)
- Tata Motors PV₹319.403.40 (1.08%)
- Bajaj Finserv₹2,002-9.00 (-0.45%)
- Grasim Industries₹3,29032.00 (0.98%)
- InterGlobe Aviation₹5,166-23.00 (-0.44%)
- Offerings
- Tools & Platforms
Tools & Calculators
- Open API
- Calculators
- SIP Calculator
- CAGR Calculator
- Compound Interest Calculator
- FD Calculator
- RD Calculator
- EPF Calculator
- Retirement Calculator
- HDFC SIP Calculator
- Mutual Fund Return Calculator
- Lumpsum Calculator
- Step Up SIP Calculator
- ETF SIP Calculator
- Brokerage Calculator
- Equity Margin Calculator
- SWP Calculator
- EMI Calculator
- MTF Calculator
- Margin Pledge Calculator
- Markets
Stocks
F&O
Mutual Funds
- More
Open Free Demat Account
Open Free Demat Account
Divi's Laboratories Performance
Price Movement
₹9080.50
₹9270.00
1 Year Performance
₹5636.50
₹9150.00
Markets Today
Historical Performance
Divi's Laboratories Share Price Today
As of 31-08-2026 03:48, Divi's Laboratories Ltd. share price today is ₹0, with a change of ₹-9060.00 (-100.00%) from the previous close of ₹9060. The stock opened at ₹9099.5 and traded between ₹9080.5 and ₹9270, with a total traded volume of 773225 shares. The company has a market capitalization of ₹240514.6 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹9150 and ₹5636.5, respectively.
Divi's Laboratories Ltd. valuation metrics include a P/E ratio of 82.2, EPS of ₹96.75, and book value of ₹13.60. Profitability indicators show ROE of 15.32% along with a dividend yield of 0.3%. Divi's Laboratories Ltd. has reported revenue of ₹11230 Cr and net profit of ₹2925 Cr.
Divi's Laboratories Ltd. technical indicators include Day RSI at 78.55, Day MFI at 81.58, Day ADX at 62.92. Additional indicators include Commodity Channel Index (CCI) at 260.8 and Williams %R at -10.1. Momentum indicators show Day MACD at 349.39, Day MACD Signal Line at 344.62, DayATR at 174.47. Rate of Change indicators for Divi's Laboratories Ltd. include ROC125 at 43.96 and ROC21 at 16.39.
Exponential moving averages include EMA5 at ₹8851.1, EMA10 at ₹8702.7, EMA12 at ₹8651.7, EMA20 at ₹8447.9, EMA26 at ₹8302.3, EMA50 at ₹7848.5, EMA100 at ₹7335.4, EMA200 at ₹6895.5. Simple moving averages include SMA5 at ₹8784.5, SMA10 at ₹8659.9, SMA20 at ₹8530.4, SMA30 at ₹8163.4, SMA50 at ₹7625.7, SMA100 at ₹7078.7, SMA150 at ₹6771.8, SMA200 at ₹6689.8.
Support levels for Divi's Laboratories are placed at First Support ₹9013.33, Second Support ₹8966.67, Third Support ₹8898.33. Resistance levels are seen at First Resistance ₹9128.33, Second Resistance ₹9196.67, Third Resistance ₹9243.33. Divi's Laboratories Ltd. shareholding pattern shows promoter holding at 51.88%, FII holding at 20.19%, DII holding at 0%, public holding at 8.53%.
Divi's Laboratories Fundamentals
Divi's Laboratories Financials
Indicator | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|
| Total Revenue | 2,974 | 2,793 | 2,578 | 2,660 | 2,357 |
| Operating Expense | 1,734 | 1,850 | 1,671 | 1,765 | 1,614 |
| Operating Profit | 1,240 | 943 | 907 | 895 | 743 |
| Depreciation | 132 | 120 | 116 | 113 | 112 |
| Interest | 6 | 6 | 6 | 8 | 3 |
| Tax | 274 | 215 | 200 | 224 | 190 |
| Net Profit | 891 | 756 | 598 | 696 | 557 |
Divi's Laboratories Technicals
Divi's Laboratories Ltd. EMA & SMA
₹9239.00
↗ Bullish Moving Average
16
↘ Bearish Moving Average
0
Divi's Laboratories Support and Resistance
Resistance
Support
Technical Indicators
Divi's Laboratories Shareholding Pattern
| Held By | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Promoter | 51.9 | 51.9 | 51.9 | 51.9 | 51.9 | 51.9 |
| FII | 18 | 19.7 | 19.4 | 20.1 | 20.3 | 20.2 |
| DII | 20.7 | 19.1 | 19.8 | 19.3 | 19.2 | 19.4 |
| Public | 9.4 | 9.3 | 9 | 8.8 | 8.6 | 8.5 |
Divi's Laboratories Delivery And Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 3.2 L | 5.61 L | 57.06% |
| Week | 2.51 L | 4.75 L | 52.86% |
| 1 Month | 3.13 L | 5.75 L | 54.48% |
| 6 Month | 2.35 L | 4.13 L | 56.92% |
Divi's Laboratories SWOT Analysis
MACD Crossover Above Signal Line
Companies with no Debt
Benjamin Graham Value Screen
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Expensive Stars (DVM)
Companies with 10% increase in share price over three months, with rising net profit growth
Strong Momentum: Price above short, medium and long term moving averages
Consistent high performing stocks over Five Years
Relative Outperformance versus Industry over 1 Month
Companies with high TTM EPS Growth
Companies that saw improvement in net profits, operating profit margin and revenues in the most recent quarter
Annual Profit Growth higher than Sector Profit Growth
Stocks gaining versus previous close, open price and RSI
New 52 week high today
High Momentum Scores (Technical Scores greater than 50)
Good quarterly growth in the recent results
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Overbought by Money Flow Index (MFI)
Effectively using its capital to generate profit - RoCE improving in last 2 years
Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year
Growth in Net Profit with increasing Profit Margin (QoQ)
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Increasing Revenue every quarter for the past 2 quarters
Increasing profits every quarter for the past 2 quarters
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Recent Results : Growth in Operating Profit with increase in operating margins (YoY)
Stock gained more than 20% in one month
MACD crossed above signal line previous end of day
Top Gainers
New 52 Week High
Volume Shockers
Stocks Outperforming their Industry Price Change in the Quarter
Divi's Laboratories Corporate Action
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 24 Jul, 2026 | 30 | FINAL | 24 Jul, 2026 | Equity Share |
| 25 Jul, 2025 | 30 | FINAL | 25 Jul, 2025 | Equity Share |
| 02 Aug, 2024 | 30 | FINAL | 02 Aug, 2024 | Equity Share |
| 11 Aug, 2023 | 30 | FINAL | 11 Aug, 2023 | Equity Share |
| 11 Aug, 2022 | 30 | FINAL | 12 Aug, 2022 | Equity Share |
| 17 Aug, 2021 | 20 | FINAL | Equity Share | |
| 25 Feb, 2020 | 16 | INTERIM | 26 Feb, 2020 | Equity Share |
| 14 Aug, 2019 | 16 | FINAL | Equity Share | |
| 31 Aug, 2018 | 10 | FINAL | Equity Share | |
| 15 Sep, 2017 | 10 | FINAL | Equity Share |
Divi's Laboratories Stock Comparison
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹1,815 | ₹900.05 | ₹1,485 | ₹1,866 | ₹2,382.90 | ₹217.90 |
| % Change | -1.41% | -2.66% | -0.22% | -0.66% | -1.43% | 1.37% |
| Revenue TTM (₹ Cr) | ₹1,935.80 | ₹2,002.34 | ₹2,250.36 | ₹9,683.45 | ₹14,737.88 | ₹9,205.28 |
| Net Profit TTM (₹ Cr) | ₹288.22 | ₹575.94 | ₹361.74 | ₹1,011.39 | ₹2,042.67 | ₹-313.62 |
| PE TTM | 105.70 | 90.40 | 87.30 | 35.20 | 48.90 | -91.20 |
| 1 Year Return | 279.59 | 10.62 | 72.83 | 27.9 | -3.38 | 13.51 |
| ROCE | 24.32 | 27.56 | 18.38 | 25.65 | 14.32 | 2.29 |
Similar Stocks
ACUTAAS
Acutaas Chemicals Ltd.
₹ 3264.80
-1.93%
GLAND
Gland Pharma Ltd.
₹ 2885.00
+0.40%
LAURUSLABS
Laurus Labs Ltd.
₹ 1938.50
+0.47%
ALKEM
Alkem Laboratories Ltd.
₹ 5355.00
+0.66%
BIOCON
Biocon Ltd.
₹ 411.10
-1.74%
GRANULES
Granules India Ltd.
₹ 837.85
+0.67%
AJANTPHARM
Ajanta Pharma Ltd.
₹ 3566.00
+0.63%
ZYDUSLIFE
Zydus Lifesciences Ltd.
₹ 1191.00
+0.15%
GLENMARK
Glenmark Pharmaceuticals Ltd.
₹ 2515.00
+2.24%
WOCKPHARMA
Wockhardt Ltd.
₹ 1975.00
+0.66%
AUROPHARMA
Aurobindo Pharma Ltd.
₹ 1645.30
+0.51%
SUNPHARMA
Sun Pharmaceutical Industries Ltd.
₹ 1920.00
+0.35%
NEULANDLAB
Neuland Laboratories Ltd.
₹ 23183.00
-1.33%
IPCALAB
Ipca Laboratories Ltd.
₹ 1953.70
-0.31%
GLAXO
GlaxoSmithKline Pharmaceuticals Ltd.
₹ 3105.00
+1.17%
PFIZER
Pfizer Ltd.
₹ 4715.00
-0.54%
ABBOTINDIA
Abbott India Ltd.
₹ 26200.00
-0.57%
TORNTPHARM
Torrent Pharmaceuticals Ltd.
₹ 5050.00
+1.02%
LUPIN
Lupin Ltd.
₹ 2171.50
+0.62%
DRREDDY
Dr. Reddy's Laboratories Ltd.
₹ 1178.00
+0.08%
CIPLA
Cipla Ltd.
₹ 1423.50
+0.25%
FAQ's on DIVISLAB
What is the current share price of Divi's Laboratories Ltd.?
What is the Market Capitalization of Divi's Laboratories Ltd.?
What are the PE and PB ratios for Divi's Laboratories Ltd.?
What is the 52-Week High and Low for Divi's Laboratories Ltd.?
What is the current dividend yield for Divi's Laboratories Ltd.?
Who are the major shareholders of Divi's Laboratories Ltd.?
Who are the peers of Divi's Laboratories Ltd. in the Pharmaceuticals & Biotechnology sector?
What is the latest dividend information for Divi's Laboratories Ltd.?
Invest Anytime, Anywhere
By signing up I certify terms, conditions & privacy policy